Index
By TNW
About Index
Trending news
Analyze
Pricing
Sign up or sign in
Celgene Corporation
Work at Celgene Corporation?
Add yourself to this profile
2936
Celgene Corporation
Global biopharmaceutical company. Tweets by Greg Geissman & Julissa Viana. Review our guidelines on our site
Edit Profile
celgene.com
Health Care
>
Medical
Technology
>
Biotechnology
B2c
Founded in
1986
More info
Elsewhere
Contributors to this profile
Companies in the same industry
Twinstrand Therapeutics
miPS Labs
TCD Pharma
Perez Forensic Strategies
AquarisPLUS Int
ID Genomics
Wellfount
numares AG
Therachon AG
Provia Laboratories
Alexa global traffic share
Twitter followers
Overview
Investments
32
Acquisitions
8
Apps
6
Add info
Employees
Team size
5000+
Locations
HQ
United States
Headquarters
Xconomy
Celgene Narrows Its Relationship With Sutro, No Acquisition Coming
Health
Xconomy
With FDA Nod, Agios, Celgene Get Speedy OK For Blood Cancer Drug
Health
Xconomy
Celgene Builds Up Cancer Drug Pipeline With BeiGene Deal
Health
Xconomy
Dragonfly, Tyler Jacks’s Disney-Backed Startup, Gets $33M in Celgene Deal
Health
Xconomy
Drug-Hunting Startup From Scripps Attracts Celgene Alum, $50M Backing
Science
$300,000,000
Added by
via
GEN
,
Xconomy
,
businesswire
Celgene Buys Delinia for $300M to Acquire Treg Therapy for Autoimmune Diseases Genetic Engineering & Biotechnology News - Biotech from Bench to Business
Xconomy
Celgene Pays Anokion $45M for Autoimmune Research, Option to Buy
Science
Funding
Health
Xconomy
Acetylon Crafts New Buyout Deal With Celgene, Spins Out Startup Regenacy
Health
Strategy
Xconomy
Celgene Touts Data From Early Study of Oral GI Drug
Health
Xconomy
Celgene Plots Speedy FDA Filing for Agios Blood Cancer Drug
Health
Science
Xconomy
Celgene Passes on Acetylon as Another Option-to-Buy Deal Flames Out
Health
Strategy
Xconomy
With Celgene Deal, Jounce Lands $261M And a “Trusting Partner”
Health
The Motley Fool
When Will Gilead Sciences, Celgene, and CVS Health Hit $100 Again?
The Motley Fool
3 Biotech Stocks to Buy Now for the Long Haul
The Motley Fool
Better Buy: Biogen Inc. vs. Celgene Corporation
The Motley Fool
Better Buy: Ziopharm Oncology, Inc. vs. Celgene
The Motley Fool
3 Stocks on Our Radar
Stock markets
Earnings
Xconomy
Agios, Celgene Jump into Immuno-Oncology in Revamped Alliance
Health
The Motley Fool
Big Drugmakers Were Key to Juno Therapeutics' Q1 Performance
The Motley Fool
Celgene's Mixed Guidance Is No Reason to Panic
Earnings
Health
Twinstrand Therapeutics
miPS Labs
TCD Pharma
Perez Forensic Strategies
AquarisPLUS Int
